TheraRadar
← Back
Data updated: Jun 28, 2026

ATLAS PHARMS LLC

Generics
Pharmaceuticals

ATLAS PHARMS LLC is a generic drug manufacturer with 1 FDA-approved products.

2016
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

ATLAS PHARMS LLC's Key Drugs

ATLAS PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

ATLAS PHARMS LLC's Recent FDA Approvals

New NDA/BLA approvals for ATLAS PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

ATLAS PHARMS LLC's Therapeutic Areas

Disease areas where ATLAS PHARMS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

ATLAS PHARMS LLC Pipeline Snapshot

Active clinical trials for ATLAS PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling